产物详情（用途，包装等） Rituxan® (rituximab) is a genetically engineered chimeric murine/human monoclonal IgG1 kappa antibody directed against the CD20 antigen. Rituximab has an approximate molecular weight of 145 kD. Rituximab is produced by mammalian cell (Chinese Hamster Ovary) suspension culture in a nutrient medium containing the antibiotic gentamicin. Gentamicin is not detectable in the final product.
Rituximab is a sterile, clear, colorless, preservative-free liquid. Rituximab is supplied at a concentration of 10 mg/Ml, which contains polysorbate 80 (0.7 mg/mL), sodium chloride (9 mg/mL), sodium citrate dihydrate (7.35 mg/mL), and Water for Injection. The pH is 6.5.
供应商信息
上海拓普韦尔生物医药科技有限公司
认证状态：未认证供应商
电话：+86-02158180488
地址：Room 315, Building 3, No. 1666, Xinyang Highway, Lin-gang Special Area of China (Shanghai) Pilot Free Trade Zone
区域：China 联系人：Bruce
联系人电话：+86-21-58180488
邮件：sales@topwellpharma.com
网址：http://www.topwellpharma.com
主要市场：Europe and America
IP：